Eli Lilly : LLY

All Eli Lilly Articles

577 Articles

Omor Ibne Ehsan | Sep 17, 2025 at 10:28 AM EDT

3 Stocks Insiders Are Buying Non-Stop

Insider buying is one of the few market signals that does not hide behind algorithms or price targets. When a…

Omor Ibne Ehsan | Sep 2, 2025 at 3:45 PM EDT

Jim Cramer Says This “Ridiculously Cheap” Healthcare Stock is a Buy

Healthcare investing has felt like walking through quicksand this year. One moment, the sector looks ready to spring forward on…

Lee Jackson | Sep 1, 2025 at 5:42 PM EDT

A Bad September to Remember? Time to Move to Safe Blue-Chip Dividend Stocks

These five blue-chip giants remain Wall Street favorites and are outstanding ideas for long-term growth and income investors.

Rich Duprey | Sep 1, 2025 at 9:31 AM EDT

Cramer Loves These Dividend Stocks

Jim Cramer, the charismatic host of CNBC’s Mad Money, has become a household name for investors seeking bold, actionable insights.…

Joel South | Aug 27, 2025 at 9:27 AM EDT

Stock Market Live August 27: S&P 500 (VOO) Flat As Investors Await Nvidia News

This article will be updated throughout the day, so check back often for more daily updates. The Vanguard S&P 500…

Rich Duprey | Aug 27, 2025 at 8:23 AM EDT

Eli Lilly’s Obesity Pill Breakthrough Shakes Up $150 Billion Weight-Loss Race

A Fierce Battle for Weight-Loss Supremacy The weight-loss drug market has become a battleground, ignited by the runaway success of…

Rich Duprey | Aug 22, 2025 at 12:13 PM EDT

Novo Nordisk Roars Back: 6 Catalysts Driving the Pharma’s Path to Dominance

A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug market,…

Joel South | Aug 19, 2025 at 9:08 AM EDT

Stock Market Live August 19: S&P 500 (VOO) Rally Still on Hold Pending Fed Talk

This article will be updated throughout the day, so check back often for more daily updates. It’s a pretty slow…

Rich Duprey | Aug 18, 2025 at 11:24 AM EDT

2 Phenomenal Dividend Growth Stocks That Insiders Are Buying Hand Over Fist

Compounding Wealth Dividend growth investing is a time-tested strategy that combines the stability of regular income with the potential for…

Joel South | Aug 7, 2025 at 9:12 AM EDT

Stock Market Live August 7: Shrugging Off Tariffs News, S&P 500 (VOO) Rises Again

This article will be updated throughout the day, so check back often for more daily updates. The Vanguard S&P 500…

Rich Duprey | Aug 6, 2025 at 11:35 AM EDT

There Is Only 1 GLP-1 Stock to Buy In 2025

Weighing the Options The introduction of Novo Nordisk’s (NYSE:NVO) Ozempic revolutionized the fight against obesity, shifting the narrative from lifestyle…

David Moadel | Aug 2, 2025 at 11:53 AM EDT

What Are the Best Dividend Growth Stocks I Should Invest In Right Now?

Investing in dividend stocks is a great way to build your wealth over time. With patience and careful stock selection,…

Rich Duprey | Jul 29, 2025 at 11:25 AM EDT

Ozempic Maker Novo Nordisk Is Plunging 20%. Time to Sell or Buy More?

Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its full-year sales…

Omor Ibne Ehsan | Jul 14, 2025 at 10:18 AM EDT

3 Dividend Growth Stocks to Turn $10,000 Into $50,000 by 2035

If you wish to turn $10,000 into $50,000 by 2035, you’re looking at a 400% gain over a 10-year horizon.…

Omor Ibne Ehsan | Jun 26, 2025 at 2:54 PM EDT

Jim Cramer’s Safest Stock For Retirees

Jim Cramer has a mixed record when it comes to choosing stocks. Therefore, he also has a mixed reputation in…

1 2 3 4 … 39

Eli Lilly : LLY

All Eli Lilly Articles

3 Stocks Insiders Are Buying Non-Stop

Jim Cramer Says This “Ridiculously Cheap” Healthcare Stock is a Buy

A Bad September to Remember? Time to Move to Safe Blue-Chip Dividend Stocks

Cramer Loves These Dividend Stocks

Stock Market Live August 27: S&P 500 (VOO) Flat As Investors Await Nvidia News

Eli Lilly’s Obesity Pill Breakthrough Shakes Up $150 Billion Weight-Loss Race

Novo Nordisk Roars Back: 6 Catalysts Driving the Pharma’s Path to Dominance

Stock Market Live August 19: S&P 500 (VOO) Rally Still on Hold Pending Fed Talk

2 Phenomenal Dividend Growth Stocks That Insiders Are Buying Hand Over Fist

Stock Market Live August 7: Shrugging Off Tariffs News, S&P 500 (VOO) Rises Again

There Is Only 1 GLP-1 Stock to Buy In 2025

What Are the Best Dividend Growth Stocks I Should Invest In Right Now?

Ozempic Maker Novo Nordisk Is Plunging 20%. Time to Sell or Buy More?

3 Dividend Growth Stocks to Turn $10,000 Into $50,000 by 2035

Jim Cramer’s Safest Stock For Retirees

XRP at Critical $2.00 Support: Extreme Fear Creates Buy Opportunity or Bull Trap?

Don’t Overcomplicate It, 3 High Yield ETFS To Buy And Never Sell

Why Meta is My Largest Position By Far

What Happens to Social Security's Cost of Living Adjustment (COLA) If the Fed Raises Rates Next Time?

What Happens To Social Security's Cost Of Living Adjustment (COLA) If The Fed Cuts Rates Again?

XRP at Critical $2.00 Support: Extreme Fear Creates Buy Opportunity or Bull Trap?

Don’t Overcomplicate It, 3 High Yield ETFS To Buy And Never Sell

Eli Lilly : LLY

All Eli Lilly Articles

3 Stocks Insiders Are Buying Non-Stop

Jim Cramer Says This “Ridiculously Cheap” Healthcare Stock is a Buy

A Bad September to Remember? Time to Move to Safe Blue-Chip Dividend Stocks

Cramer Loves These Dividend Stocks

Stock Market Live August 27: S&P 500 (VOO) Flat As Investors Await Nvidia News

Eli Lilly’s Obesity Pill Breakthrough Shakes Up $150 Billion Weight-Loss Race

Novo Nordisk Roars Back: 6 Catalysts Driving the Pharma’s Path to Dominance

Stock Market Live August 19: S&P 500 (VOO) Rally Still on Hold Pending Fed Talk

2 Phenomenal Dividend Growth Stocks That Insiders Are Buying Hand Over Fist

Stock Market Live August 7: Shrugging Off Tariffs News, S&P 500 (VOO) Rises Again

There Is Only 1 GLP-1 Stock to Buy In 2025

What Are the Best Dividend Growth Stocks I Should Invest In Right Now?

Ozempic Maker Novo Nordisk Is Plunging 20%. Time to Sell or Buy More?

3 Dividend Growth Stocks to Turn $10,000 Into $50,000 by 2035

Jim Cramer’s Safest Stock For Retirees

XRP at Critical $2.00 Support: Extreme Fear Creates Buy Opportunity or Bull Trap?

Don’t Overcomplicate It, 3 High Yield ETFS To Buy And Never Sell

Why Meta is My Largest Position By Far

Featured Reads

What Happens to Social Security's Cost of Living Adjustment (COLA) If the Fed Raises Rates Next Time?

What Happens To Social Security's Cost Of Living Adjustment (COLA) If The Fed Cuts Rates Again?